Cyprumed is a drug delivery company with a patent protected platform technology for the oral and nasal delivery of therapeutic peptides and proteins. Cyprumed offers the development of oral and nasal formulations for novel and generic biologics such as peptides and also larger proteins. The delivery technology is entirely based on GRAS excipients. USP and EP monographs are available for all single excipients.